Every year, over 20 million people globally are diagnosed with cancer and close to 9.5 million people will reportedly succumb ...
Strand Life Sciences, a subsidiary of Reliance Industries, has introduced CancerSpot, a blood-based test for early cancer ...
Bengaluru-based Strand Life Sciences, a Reliance Industries subsidiary, has partnered with Agilent, Celemics, and SOPHiA ...
Leading genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a ...
These advancements are customised to meet the unique requirements of the Indian population and provide unmatched precision, economy, and efficiency, according to a release by the company. Advisory ...
Health and Me on MSN9d
Researchers Launch CancerSpot-A Blood test That Could Detect Cancer Even Before Symptoms AppearStrand Life Sciences has introduced CancerSpot, a blood-based test designed for the early detection of multiple cancers. This ...
Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling technology for early detection of multiple cancers. The test aims to address the growing cancer burden in ...
Called CancerSpot, the test uses the latest globally accepted methylation profiling technology to identify cancer tumour DNA ...
Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling for early detection of multiple ...
Speaking at the opening of Strand’s new Genomics Diagnostics & Research Centre in Bengaluru, company CEO and Co-Founder Dr.
Strand Life Sciences launches CancerSpot, a blood-based test for early cancer detection, using advanced methylation profiling ...
Strand Life Sciences subsidiary of Reliance Life Sciences launches blood test for early detection of multiple cancers: Our Bureau, Bengaluru Monday, December 2, 2024, 14:40 Hrs [I ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback